Products

What will AGI do for Betahistine mesilate?

This classification denotes a vasodilating agent with the molecular formula C8H12N2.2CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X1L0E3R43Y, chemically known as 2-pyridineethanamine, n-methyl-, dimethanesulfonate but more generally known as betahistine mesilate, which bears US NIH Compound Identifier 198334. The base compound, Betahistine, most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. European Medicines Agency schedules Betahistine mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00773MIG. Most nations, for tariff and trade purposes, schedule betahistine mesilate under HS 29333999 and SITC 51574. As of Q4 2014, BETAHISTINE MESILATE remains US FDA's Preferred Term for this commodity. SMILES: CNCCC1CCCCN1.CS(=O)(=O)O.CS(=O)(=O)O.

How AGI delivers it

Four ways AGI delivers for Betahistine mesilate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Betahistine mesilate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Betahistine mesilate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Betahistine mesilate connects

measured by

  • Assay Puritymodel
  • Loss On Dryingmodel
  • Residual Solventmodel